ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 196 filers reported holding ANIKA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 15.80 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $552,257 | +53.5% | 21,257 | +69.7% | 0.01% | +66.7% |
| Q1 2023 | $359,661 | -3.0% | 12,523 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $370,681 | -44.2% | 12,523 | -55.1% | 0.00% | -40.0% |
| Q3 2022 | $664,000 | +6.6% | 27,911 | 0.0% | 0.01% | +25.0% |
| Q2 2022 | $623,000 | +208.4% | 27,911 | +389.7% | 0.00% | +100.0% |
| Q3 2020 | $202,000 | -79.1% | 5,700 | -77.7% | 0.00% | -83.3% |
| Q2 2020 | $966,000 | +22.4% | 25,600 | -6.2% | 0.01% | -14.3% |
| Q1 2020 | $789,000 | -1.9% | 27,300 | +76.1% | 0.01% | +100.0% |
| Q4 2019 | $804,000 | -27.1% | 15,500 | -22.9% | 0.01% | -30.0% |
| Q3 2019 | $1,103,000 | +239.4% | 20,100 | +151.2% | 0.01% | +233.3% |
| Q2 2019 | $325,000 | -54.4% | 8,000 | -62.3% | 0.00% | -62.5% |
| Q4 2018 | $713,000 | -90.6% | 21,200 | -88.5% | 0.01% | -91.2% |
| Q1 2014 | $7,583,000 | – | 184,507 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caligan Partners LP | 591,675 | $17,513,580 | 14.58% |
| Trigran Investments, Inc. | 1,564,541 | $46,310,413 | 4.64% |
| DIKER MANAGEMENT LLC | 22,458 | $664,757 | 0.77% |
| Virtus Fund Advisers, LLC | 3,490 | $103,304 | 0.74% |
| Portolan Capital Management | 207,900 | $6,153,840 | 0.61% |
| Virtus Investment Advisers, Inc. | 16,086 | $476,146 | 0.32% |
| Ranger Investment Management | 140,205 | $4,150,068 | 0.31% |
| BOOTHBAY FUND MANAGEMENT, LLC | 367,510 | $10,878,296 | 0.25% |
| Riverwater Partners LLC | 9,778 | $289,429 | 0.25% |
| Legato Capital Management LLC | 7,556 | $223,658 | 0.04% |